» Articles » PMID: 15609132

Vascular Endothelial Growth Factor (VEGF) Levels and Mutation of the BRCA1 Gene in Breast Cancer Patients

Overview
Specialty Oncology
Date 2004 Dec 21
PMID 15609132
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the study was to compare VEGF serum levels in breast cancer patients with and without BRCA1 gene mutation. We enrolled 80 patients, 22 premenopausal and 58 postmenopausal. We found statistically significant lower levels of VEGF in patients with BRCA1 gene mutation as compared with breast cancer patients without this mutation.

Citing Articles

High FSH levels impair VEGF secretion of human, frozen-thawed ovarian cortical tissue in vitro.

Einenkel R, Schallmoser A, Sanger N Sci Rep. 2024; 14(1):3287.

PMID: 38332226 PMC: 10853201. DOI: 10.1038/s41598-024-53402-8.


Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation.

Wong H, Parkinson C, Ledermann J, Brenton J, Merger M, Shaw A Gynecol Oncol Case Rep. 2013; 3:7-10.

PMID: 24371652 PMC: 3862224. DOI: 10.1016/j.gynor.2012.10.003.


VEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer.

Saponaro C, Malfettone A, Ranieri G, Danza K, Simone G, Angelo Paradiso PLoS One. 2013; 8(1):e53070.

PMID: 23326384 PMC: 3543407. DOI: 10.1371/journal.pone.0053070.